Skip to main content
European Commission logo print header

TOPO-TB

Objectif

Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.
With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme of
the bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples,
will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resource
adaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detection
at the point of care patient level.

Appel à propositions

H2020-SMEInst-2014-2015

Voir d’autres projets de cet appel

Sous appel

H2020-SMEINST-1-2015

Régime de financement

SME-1 - SME instrument phase 1

Coordinateur

ZYMONOSTICS APS
Contribution nette de l'UE
€ 50 000,00
Adresse
ABOGADE 15
8200 AARHUS N
Danemark

Voir sur la carte

PME

L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.

Oui
Région
Danmark Midtjylland Østjylland
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 71 429,00